Category Archives: Cardiovascular

Jeito Capital co-leads EUR 65 million (USD 71 M) financing in Corteria Pharmaceuticals, a French biopharmaceutical company developing novel treatments for cardiovascular diseases

Jeito Capital co-leads EUR 65 million (USD 711M) financing in Corteria Pharmaceuticals, a French biopharmaceutical company developing novel treatments for cardiovascular diseases Jeito Capital co-leads oversubscribed financing Corteria,a late preclinical stage company, is developing first-in-class therapies with promising novel approaches for unaddressed heart failure subpopulations, addressing high unmet medical needs Jeito Capital marks its first […]

Incorporation of Shared Decision-Making in International Cardiovascular Guidelines

Key Points Question  Is shared decision-making (SDM) integrated into cardiovascular guideline recommendations on pharmacotherapy? Findings  This cross-sectional study of 65 guidelines (2655 pharmacotherapy recommendations) published from 2012 to 2022 found that 6% of recommendations incorporated SDM in some form. The proportion of pharmacotherapy recommendations incorporating SDM was comparable across societies, with no trend for change […]

High intake of several emulsifier E numbers linked to increased cardiovascular disease risk

Credit: Pixabay/CC0 Public Domain High intake of several emulsifiers (part of the “E numbers” group of food additives), widely used in industrially processed foods to improve texture and extend shelf-life, is associated with increased risk of cardiovascular disease (CVD), suggests a study published by The BMJ today. Given that these food additives are used ubiquitously […]

Private equity-backed cardiology management group acquires another Florida practice, its 5th of 2023

“I am honored to be leading this group as it starts a new path with a collaborative and patient-centered approach to deliver the best care possible with a vision to restore genuine patient care, where patients are embraced promptly, heard empathetically, and treated comprehensively in a care setting that emphasizes preventive measures to proactively keep […]

Deaths from obesity-related CVD have skyrocketed in US, especially among Black adults

“The number of people with obesity is rising in every country across the world,” lead author Zahra Raisi-Estabragh, MD, a cardiologist and clinical lecturer the William Harvey Research Institute in London, said in a prepared statement from the American Heart Association. “Our study is the first to demonstrate that this increasing burden of obesity is […]

How much exercise is too much? Georgia Southern researchers study cardiovascular health in ultramarathon runners to better understand impacts of physical activity

Home > Press Releases > How much exercise is too much? Georgia Southern researchers study cardiovascular health in ultramarathon runners to better understand impacts of physical activity September 6, 2023 Drs. Grosicki and Babcock (University of Colorado, Anschutz Medical Campus) work through the night to collect cardiovascular measures on race finishers. Is too much of […]

5 risk factors contribute to 50% of cardiovascular disease incidents

A study found that more than 50 percent of incidents of cardiovascular disease and approximately 20 percent of deaths could be attributed to five modifiable risk factors. The study, conducted by researchers at the German Center for Cardiovascular Research and published Aug. 23 in The New England Journal of Medicine, analyzed data from 112 global […]

Access to this page has been denied

Midland Health offers a free support group for all community members interested in learning about diabetic and cardiovascular health. COACH (Community Outreach and Cardiovascular Health) is a group of people diagnosed with heart disease who share everyday experiences or concerns and provide each other with encouragement, comfort and advice. CODE (Community Outreach for Diabetes Education) […]

Pitavastatin reduces cardiovascular event risk among patients with HIV

Bookmark 1.  In this randomized controlled trial, among patients living with human immunodeficiency virus (HIV) at low-to-moderate risk of cardiovascular disease, pitavastatin calcium was superior to placebo in reducing the risk of a major adverse cardiovascular event (MACE). 2. The trial was stopped early due to evidence of the efficacy and safety of pitavastatin. Evidence […]

Diagnostic Tool Doubles Cardiovascular Diagnoses in Patients With COPD or Diabetes

A simple diagnostic strategy increased new cardiovascular disease diagnoses in patients with COPD or type 2 diabetes, urging its implementation in primary care. An easy-to-use diagnostic strategy more than doubled the number of new diagnoses of cardiovascular disease in patients with COPD or type 2 diabetes. According to the authors, this diagnostic tool should be […]